Torrent Pharma Gains on Citi Upgrade

  Published 1 year ago

Torrent Pharmaceuticals' stock price is rising after Citigroup increased its price target to ₹4,000 per share. This upgrade follows the company's recently announced Q4FY25 financial results, signaling positive analyst sentiment.

  • Citi raised Torrent Pharma's price target.
  • Upgrade driven by Q4FY25 results.
  • Stock is currently trading higher.

You might like these

June 2025 ESI Payroll Growth Highlights

Tata Steel Shares Slip Chrome Demand

Glenmark Stock Jumps Cancer Drug Deal

ITC Announces Record Dividend & Profit Surge

Meta Faces $8B Data Privacy Trial

DCI Wins Paradip Dredging, Shares Fall

Maruti Suzuki Stock Soars on GST Cuts

News that matters the most ⚡